| Title : Forxiga (dapagliflozin): Plausible role in the treatment of diabetes-associated neurological disorders - Shaikh_2016_Biotechnol.Appl.Biochem_63_145 |
| Author(s) : Shaikh S , Rizvi SM , Shakil S , Riyaz S , Biswas D , Jahan R |
| Ref : Biotechnol Appl Biochem , 63 :145 , 2016 |
| Abstract : |
| PubMedSearch : Shaikh_2016_Biotechnol.Appl.Biochem_63_145 |
| PubMedID: 25402624 |
| Title : Invokana (Canagliflozin) as a dual inhibitor of acetylcholinesterase and sodium glucose co-transporter 2: advancement in Alzheimer's disease- diabetes type 2 linkage via an enzoinformatics study - Rizvi_2014_CNS.Neurol.Disord.Drug.Targets_13_447 |
| Author(s) : Rizvi SM , Shakil S , Biswas D , Shaikh S , Bagga P , Kamal MA |
| Ref : CNS Neurol Disord Drug Targets , 13 :447 , 2014 |
| Abstract : |
| PubMedSearch : Rizvi_2014_CNS.Neurol.Disord.Drug.Targets_13_447 |
| PubMedID: 24059302 |
| Title : Current acetylcholinesterase-inhibitors: a neuroinformatics perspective - Shaikh_2014_CNS.Neurol.Disord.Drug.Targets_13_391 |
| Author(s) : Shaikh S , Verma A , Siddiqui S , Ahmad SS , Rizvi SM , Shakil S , Biswas D , Singh D , Siddiqui MH , Tabrez S , Kamal MA |
| Ref : CNS Neurol Disord Drug Targets , 13 :391 , 2014 |
| Abstract : |
| PubMedSearch : Shaikh_2014_CNS.Neurol.Disord.Drug.Targets_13_391 |
| PubMedID: 24059296 |